Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,385 | -18,522 | -9,499 | -6,227 | -11,345 |
| Depreciation Amortization | -29 | -208 | -772 | -103 | -50 |
| Other Working Capital | -302 | 1,276 | -182 | -189 | -117 |
| Other Operating Activity | -2,636 | 6,412 | 2,468 | -101 | -4,019 |
| Operating Cash Flow | $-17,352 | $-11,041 | $-7,985 | $-6,620 | $-15,530 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,617 | -22,816 | N/A | 1,850 | 500 |
| PPE Investments | -62 | -41 | -50 | N/A | -16 |
| Other Investing Activity | 0 | 196 | 896 | 340 | -1,030 |
| Investing Cash Flow | $9,554 | $-22,661 | $846 | $2,190 | $-546 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 926 | N/A |
| Common Stock Issued | 8,171 | 24,841 | 12,341 | 7,129 | 13,598 |
| Financing Cash Flow | $8,171 | $24,841 | $12,341 | $8,055 | $13,598 |
| Beginning Cash Position | 9,826 | 18,688 | 13,487 | 9,862 | 12,340 |
| End Cash Position | 10,199 | 9,826 | 18,688 | 13,487 | 9,862 |
| Net Cash Flow | $373 | $-8,862 | $5,202 | $3,625 | $-2,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,352 | -11,041 | -7,985 | -6,620 | -15,530 |
| Capital Expenditure | -62 | -41 | -50 | N/A | -16 |
| Free Cash Flow | -17,414 | -11,082 | -8,035 | -6,620 | -15,546 |